Correlation Between Spyre Therapeutics and Match
Specify exactly 2 symbols:
By analyzing existing cross correlation between Spyre Therapeutics and Match Group 5625, you can compare the effects of market volatilities on Spyre Therapeutics and Match and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Match. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Match.
Diversification Opportunities for Spyre Therapeutics and Match
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spyre and Match is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Match Group 5625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Match Group 5625 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Match. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Match Group 5625 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Match go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Match
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Match. In addition to that, Spyre Therapeutics is 8.51 times more volatile than Match Group 5625. It trades about -0.27 of its total potential returns per unit of risk. Match Group 5625 is currently generating about -0.11 per unit of volatility. If you would invest 9,759 in Match Group 5625 on January 16, 2025 and sell it today you would lose (168.00) from holding Match Group 5625 or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Match Group 5625
Performance |
| Timeline |
| Spyre Therapeutics |
| Match Group 5625 |
Spyre Therapeutics and Match Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Match
The main advantage of trading using opposite Spyre Therapeutics and Match positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Match can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Match will offset losses from the drop in Match's long position.| Spyre Therapeutics vs. Albertsons Companies | Spyre Therapeutics vs. Tradeshow Marketing | Spyre Therapeutics vs. Village Super Market | Spyre Therapeutics vs. Singapore Airlines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |